Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11897944 | 0.91 | MAPT (0.36) | MAPTPOLBTDP1ALDH1A1NPSR1 | |
| SCHEMBL29300080 | 0.88 | ALDH1A1 (0.39) | MAPTPOLBTDP1ALDH1A1NPSR1 | |
| SCHEMBL30596885 | 0.88 | MAPT (0.37) | MAPTPOLBTDP1ALDH1A1NPSR1 | |
| SCHEMBL30596886 | 0.88 | MAPT (0.37) | MAPTPOLBTDP1ALDH1A1NPSR1 | |
| SCHEMBL11897246 | 0.87 | MAPT (0.34) | MAPTPOLBTDP1ALDH1A1NPSR1 | |
| SCHEMBL28673279 | 0.87 | MAPT (0.34) | MAPTPOLBTDP1ALDH1A1NPSR1 | |
| SCHEMBL10180801 | 0.85 | MAPT (0.36) | MAPTPOLBTDP1ALDH1A1NPSR1 | |
| SCHEMBL7155183 | 0.85 | MAPT (0.36) | MAPTPOLBTDP1ALDH1A1NPSR1 | |
| SCHEMBL30919445 | 0.84 | MAPT (0.33) | MAPTPOLBTDP1ALDH1A1NPSR1 | |
| SCHEMBL1148785 | 0.83 | MAPT (0.39) | MAPTPOLBTDP1ALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 597 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12573655-B2 | Lithium-sulfur secondary battery | LG ENERGY SOLUTION, LTD. (KR) | 2026-03-10 | — | — | US | claimed |
| US-20250316795-A1 | HIGH HEAT CAPACITY MATERIALS FOR IMPROVED SAFETY OF HIGH ENERGY DENSITY BATTERIES | ENEVATE CORP (US) | 2025-10-09 | — | — | US | claimed |
| US-12438194-B2 | Electrolyte systems including chalcogenides and compound containing electron withdrawing group, and electrochemical cell including the same | Lyten, Inc. (US) | 2025-10-07 | — | — | US | claimed |
| US-20250286126-A1 | ELECTROLYTE SYSTEMS INCLUDING CHALCOGENIDES AND COMPOUND CONTAINING ELECTRON WITHDRAWING GROUP, AND ELECTROCHEMICAL CELL INCLUDING THE SAME | Lyten, Inc. | 2025-09-11 | — | — | US | claimed |
| US-20250286144-A1 | ELECTROLYTE SYSTEMS INCLUDING PERFORMANCE-ENHANCING ADDITIVES, AND ELECTROCHEMICAL CELLS INCLUDING THE SAME | Lyten, Inc. | 2025-09-11 | — | — | US | claimed |
| US-20250286127-A1 | ELECTROLYTE SYSTEMS INCLUDING ELECTRON WITHDRAWING COMPOUNDS WITH AN ALPHA-BETA MOTIF FOR IMPROVING PERFORMANCE OF LITHIUM-BASED SECONDARY BATTERIES | Lyten, Inc. | 2025-09-11 | — | — | US | claimed |
| US-20250286141-A1 | ELECTROLYTE SYSTEMS INCLUDING PERFORMANCE-ENHANCING ADDITIVES, AND ELECTROCHEMICAL CELLS INCLUDING THE SAME | Lyten, Inc. | 2025-09-11 | — | — | US | claimed |
| WO-2025111296-A1 | ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES USING THE SAME | II-VI DELAWARE, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-20230420738-A1 | ELECTROLYTE ADDITIVE, ELECTROLYTE AND LITHIUM-ION BATTERY | GUANGZHOU TINCI MATERIALS TECHNOLOGY CO., LTD. (CN) | 2023-12-28 | — | — | US | claimed |
| EP-4290636-A1 | ELECTROLYTE ADDITIVE, ELECTROLYTE, AND LITHIUM-ION BATTERY | Guangzhou Tinci Materials Technology Co., Ltd. (CN) | 2023-12-13 | — | — | EP | claimed |
| EP-3038194-A1 | RECHARGEABLE LITHIUM BATTERY | Samsung SDI Co., Ltd. (KR) | 2016-06-29 | — | — | EP | claimed |
| US-9196903-B2 | Nonaqueous-electrolyte batteries and nonaqueous electrolytic solutions | MITSUBISHI CHEMICAL CORPORATION (JP) | 2015-11-24 | — | — | US | claimed |
| EP-2741362-A1 | Electrolyte for rechargeable lithium battery and rechargeable lithium battery including the same | Samsung SDI Co., Ltd. (KR) | 2014-06-11 | — | — | EP | claimed |
| CN-103855428-A | Electrolyte for rechargeable lithium battery and rechargeable lithium battery including the same | SAMSUNG SDI CO LTD | 2014-06-11 | — | — | CN | claimed |
| CN-103509168-A | Micropore polyurethane composition, preparation method and applications | BAYER MATERIAL SCIENCE CHINA CO LTD | 2014-01-15 | — | — | CN | claimed |
| US-20130084493-A1 | NONAQUEOUS-ELECTROLYTE BATTERIES AND NONAQUEOUS ELECTROLYTIC SOLUTIONS | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-04-04 | — | — | US | claimed |
| CN-102643303-A | Preparation method of fluoride anti-fingerprint agent | FUXIN HENGTONG FLUORINE CHEMICALS CO LTD | 2012-08-22 | — | — | CN | claimed |
| CN-101687973-A | Stabilized premix for rigid polyurethane foam | CENTRAL GLASS CO LTD | 2010-03-31 | — | — | CN | claimed |
| CN-100465204-C | Process for producing synthetic resin foam | DAIKIN IND LTD (JP) | 2009-03-04 | — | — | CN | claimed |
| CN-1585789-A | Method for producing synthetic resin foam | DAIKIN IND LTD (JP) | 2005-02-23 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12573655-B2 | Lithium-sulfur secondary battery | HCN2, HCN4, CACNA1F | MAPT 2407/4885POLB 2473/4885TDP1 3952/4885 |
| US-20230420738-A1 | ELECTROLYTE ADDITIVE, ELECTROLYTE AND LITHIUM-ION BATTERY | SLC8A1, SLC9A1, LAGE3 | MAPT 732/4885POLB 540/4885TDP1 1202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.